Home/Filings/4/0000899243-22-015802
4//SEC Filing

UNITED BIOMEDICAL INC 4

Accession 0000899243-22-015802

CIK 0001851657other

Filed

Apr 26, 8:00 PM ET

Accepted

Apr 27, 8:36 PM ET

Size

6.3 KB

Accession

0000899243-22-015802

Insider Transaction Report

Form 4
Period: 2022-04-25
Transactions
  • Purchase

    Class A common stock

    2022-04-25$3.37/sh+8,038$27,0735,193,454 total
Holdings
  • Class A common stock

    (indirect: Held by United Biomedical Inc., Asia)
    4,212,495
Footnotes (3)
  • [F1]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The price reported is a weighted average price.
  • [F3]Held by United Biomedical, Asia Inc. ("UBIA"). The Reporting Person, through a subsidiary, holds a majority equity interest in UBIA and may be deemed to be the beneficial owner of the shares held by UBIA. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by UBIA in which the Reporting Person has no pecuniary interest.

Issuer

Vaxxinity, Inc.

CIK 0001851657

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0000896839

Filing Metadata

Form type
4
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 8:36 PM ET
Size
6.3 KB